Unique ID issued by UMIN | UMIN000010843 |
---|---|
Receipt number | R000012696 |
Scientific Title | Randomized controlled trial to evaluate the efficacy of concurrent liquid-based cytology (LBC) and HPV DNA testing versus LBC alone for the primary cervical cancer screening |
Date of disclosure of the study information | 2013/06/01 |
Last modified on | 2015/12/24 18:54:25 |
Randomized controlled trial to evaluate the efficacy of concurrent liquid-based cytology (LBC) and HPV DNA testing versus LBC alone for the primary cervical cancer screening
Cervical cancer screening trial by randomization of HPV testing intervention for upcoming screening (CITRUS study)
Randomized controlled trial to evaluate the efficacy of concurrent liquid-based cytology (LBC) and HPV DNA testing versus LBC alone for the primary cervical cancer screening
Cervical cancer screening trial by randomization of HPV testing intervention for upcoming screening (CITRUS study)
Japan |
cervical cancer
Obstetrics and Gynecology |
Malignancy
NO
The aim of this study is to assess efficacy of the screening with concurrent liquid-based cytology and HPV DNA testing for the primary cervical cancer screening over 7 years.
Efficacy
Confirmatory
Pragmatic
Not applicable
The incidence of CIN3 or worse during whole periods
1) The incidence of CIN3 or worse at baseline, and two years, four years, and six years post baseline
2) The incidence of CIN2 or worse at baseline, and two years, four years, and six years post baseline
3) The incidence of CIN1 or worse at baseline, and two years, four years, and six years post baseline
4) The incidence of invasive cancer at baseline, and two years, four years, and six years post baseline
5) The number of cervical cytology performance
6) The number of colposcopy and biopsy performance
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
YES
NO
Institution is not considered as adjustment factor.
NO
Central registration
2
Prevention
Other |
Cervical cancer screening by using liquid based cytology as a standard screening modality
Cervical cancer screening by using liquid based cytology plus HPV DNA testing as an experimentary screening modality
30 | years-old | <= |
65 | years-old | > |
Female
1) Women aged 30-64 years old.
2) Participants provided written informed consent.
1) Women who will receive planed HPV DNA testing by local governmental cervical cancer program next six years.
2) Women who have had cervical invasive cancer before.
3) Women who have underwent cervical conization.
4) Women who have underwent hysterectomy.
5) Women who have had or have the cytological abnormalities and are under follow-up.
6) Pregnant women.
7) Women judged ineligible for this trial by physician.
30000
1st name | |
Middle name | |
Last name | Daisuke Aoki |
School of Medicine, Keio University
Department of Obstetrics and Gynecology
35 Shinanomachi, Shinjuku, Tokyo, 160-8582, Japan
03-3353-1211(62391)
aoki@z7.keio.jp
1st name | |
Middle name | |
Last name | Daisuke Aoki |
School of Medicine, Keio University
Department of Obstetrics and Gynecology
35 Shinanomachi, Shinjuku, Tokyo, 160-8582, Japan
03-3353-1211(62391)
aoki@z7.keio.jp
The Japanese Society of Clinical Cytology
The Japanese Society of Clinical Cytology
Other
NO
本研究に協力している41カ所(山梨県)および19カ所(千葉県柏市)の検診実施施設
2013 | Year | 06 | Month | 01 | Day |
Unpublished
No longer recruiting
2013 | Year | 04 | Month | 22 | Day |
2013 | Year | 06 | Month | 01 | Day |
2021 | Year | 03 | Month | 31 | Day |
2013 | Year | 05 | Month | 30 | Day |
2015 | Year | 12 | Month | 24 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012696